Incorporating cytologic adequacy assessment into precision oncology workflow using telepathology: An institutional experience.
Wael Al ZoughbiDavid KimSusan Ann AlpersteinKentaro OharaJyothi ManoharNoah GrecoFrancesca KhaniBrian D RobinsonRema A RaoOlivier ElementoJuan Miguel MosqueraMomin T SiddiquiPublished in: Cancer cytopathology (2021)
These results support the incorporation of ROSE into the workflow of precision oncology to obtain high-quality tissue samples from metastatic lesions. In addition, NGS testing of concurrent cytology specimens with adequate cellularity can be a surrogate for NGS testing of biopsy specimens.